Review of Selected NMEs 2023
U.S. Pharmacist » Lung Cancer
by
5M ago
Spotlighting newly approved medications that treat anemia due to chronic kidney disease, breast cancer, leukemia, and lung cancer ..read more
Visit website
A Look at NSCLC and Its Current and Emerging Therapies
U.S. Pharmacist » Lung Cancer
by
8M ago
Oncology pharmacists can identify drug-related problems associated with conventional and emerging NSCLC therapies and educate about side effects, monitoring, and drug interactions ..read more
Visit website
Postmenopausal Hormone Therapy Lowers Risk of Lung Cancer
U.S. Pharmacist » Lung Cancer
by
9M ago
..read more
Visit website
Postmenopausal Hormone Therapy Lowers Risk of Lung Cancer
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
Cost Effectiveness of Risk-Based Lung Cancer Screening
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
Targeted Therapies Underused in Medicaid Programs
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
Impact of NSAIDs on Immunotherapy Efficacy in NSCLC
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
Review of Selected NMEs 2022
U.S. Pharmacist » Lung Cancer
by
1y ago
..read more
Visit website
FDA Grants Priority Review to Atezolizumab for Early Non-Small Cell Lung Cancer
U.S. Pharmacist » Lung Cancer
by
2y ago
..read more
Visit website
Disparities in Lung Cancer-Screening Eligibility Persist
U.S. Pharmacist » Lung Cancer
by
2y ago
..read more
Visit website

Follow U.S. Pharmacist » Lung Cancer on FeedSpot

Continue with Google
Continue with Apple
OR